Skip to main content

Table 3 Multivariate Cox proportional hazards regression analysis evaluating the impact of various clinicopathologic factors on the risk of biochemical recurrence after salvage ADT

From: Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer

 

HR(95% CI)

p-value

Treatment group

  

  Ultra-early salvage ADT

Reference

 

  Early salvage ADT

7.691 (1.466-141.6)

0.0118*

Preoperative PSA, ng/ml

  

  <20

Reference

 

  ≥20

2.065 (0.529-6.761)

0.2744

Pathologic Gleason score

  

  ≤7

Reference

 

  ≥8

4.739 (1.330-15.73)

0.0182*

  1. ADT, androgen deprivation therapy; *statistically significant; PSA, prostate-specific antigen.